Charles E Sheedy insider trades: Nuo Therapeutics (AURX) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Charles reports to the SEC
Open-market buys and sales
7 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jul 30, 2025 | AURX | ↑ Buy | 133,333 | $1.50 | $200K | Direct | Aug 1, 2025 (2d) |
| Sep 18, 2024 | AURX | ↑ Buy | 125,000 | $0.75 | $94K | Direct | Sep 19, 2024 (1d) |
| May 20, 2024 | AURX | ↑ Buy | 100,000 | $0.75 | $75K | Direct | May 21, 2024 (1d) |
| Dec 19, 2023 | AURX | ↑ Buy | 150,000 | $0.50 | $75K | Direct | Dec 20, 2023 (1d) |
| Aug 1, 2023 | AURX | ↑ Buy | 62,500 | $2.00 | $125K | Direct | Aug 4, 2023 (3d) |
| Apr 29, 2022 | AURX | ↑ Buy | 804,868 | $1.00 | $805K | Direct | May 2, 2022 (3d) |
| Aug 10, 2017 | AURX | ↑ Buy | 5,220,000 | $0.22 | $1.2M | Direct | Aug 14, 2017 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other AURX insiders
Open-market trades in the last 12 months
About Charles E Sheedy's insider trades
Charles E Sheedy is a 10% owner of Nuo Therapeutics (AURX). Since Aug 10, 2017, Charles has reported 7 open-market purchases worth $2.5M and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AURX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.